| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/13/2002 | EP1185666A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production |
| 03/13/2002 | EP1185652A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 03/13/2002 | EP1185645A1 Adipocyte complement related protein homolog zacrp7 |
| 03/13/2002 | EP1185642A2 Compositions and methods for the treatment of tumor |
| 03/13/2002 | EP1185637A1 ANTISENSE TO i c-myc /i FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE |
| 03/13/2002 | EP1185623A1 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors |
| 03/13/2002 | EP1185547A2 Gene expression modulated in gastrointestinal inflammation |
| 03/13/2002 | EP1185545A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 03/13/2002 | EP1185543A1 50 human secreted proteins |
| 03/13/2002 | EP1185542A2 Purine derivatives |
| 03/13/2002 | EP1185540A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
| 03/13/2002 | EP1185539A1 Organosilyl compounds having nuclear hormone receptor modulating activity |
| 03/13/2002 | EP1185536A2 Hemisynthetic method and intermediates thereof |
| 03/13/2002 | EP1185535A1 Cyclocarbamate and cyclic amide derivatives |
| 03/13/2002 | EP1185532A1 Peroxynitrite decomposition catalysts and methods of use thereof |
| 03/13/2002 | EP1185530A1 Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists |
| 03/13/2002 | EP1185529A1 Pyrazolobenzodiazepines as cdk2 inhibitors |
| 03/13/2002 | EP1185528A1 Inhibitors of il-12 production |
| 03/13/2002 | EP1185527A1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds |
| 03/13/2002 | EP1185526A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use |
| 03/13/2002 | EP1185525A1 4-heterocyclylsulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists |
| 03/13/2002 | EP1185524A2 3-heteroarylalkyl substituted gaba analogs |
| 03/13/2002 | EP1185522A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions containing them |
| 03/13/2002 | EP1185521A1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors |
| 03/13/2002 | EP1185517A1 Antibiotic prodrugs |
| 03/13/2002 | EP1185516A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 03/13/2002 | EP1185515A1 Method of inhibiting neurotrophin-receptor binding |
| 03/13/2002 | EP1185514A1 Pharmaceutical compositions and methods for use |
| 03/13/2002 | EP1185513A2 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors |
| 03/13/2002 | EP1185512A2 INHIBITORS OF FACTOR Xa |
| 03/13/2002 | EP1185511A2 Inhibitors of factor xa |
| 03/13/2002 | EP1185509A2 INHIBITORS OF FACTOR Xa |
| 03/13/2002 | EP1185508A2 Inhibitors of factor xa |
| 03/13/2002 | EP1185493A1 Quinones for treatment of diseases |
| 03/13/2002 | EP1185316A1 Devices and compounds for treating arterial restenosis |
| 03/13/2002 | EP1185306A1 Use of viral vectors and charged molecules for gene therapy |
| 03/13/2002 | EP1185305A1 Ligand-conjugated oligomeric compounds |
| 03/13/2002 | EP1185304A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 03/13/2002 | EP1185301A1 Emulsion vehicle for poorly soluble drugs |
| 03/13/2002 | EP1185300A1 Method of treating carcinoma using antibody therapy and ameliorating side effects associated with such therapy |
| 03/13/2002 | EP1185289A2 Amino acids from fish and soy proteins for improvement of insulin sensitivity |
| 03/13/2002 | EP1185287A2 Use of estrogen receptor agonists or antagonists for treating growth, bone disorders |
| 03/13/2002 | EP1185285A1 49 human secreted proteins |
| 03/13/2002 | EP1185281A1 Combination of glucosamine with herbal extracts of tripterygium, ligustrum and erycibe |
| 03/13/2002 | EP1185277A1 Methods for modulating fxr receptor activity |
| 03/13/2002 | EP1185276A1 Isophosphoramide mustard analogs and use thereof |
| 03/13/2002 | EP1185275A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors |
| 03/13/2002 | EP1185274A1 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4 |
| 03/13/2002 | EP1185273A1 Antifungal oral composition containing itraconazole and process for preparing same |
| 03/13/2002 | EP1185272A2 Novel use of 1-[4-(5-cyanoindol-3yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiological acceptable salts |
| 03/13/2002 | EP1185271A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185270A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185269A1 Glycosyltransferase inhibitors |
| 03/13/2002 | EP1185268A1 The therapeutic use of d-threo-methylphenidate for the treatment of attention-deficit hyperactivity disorder |
| 03/13/2002 | EP1185267A1 Dermal anesthetic agents |
| 03/13/2002 | EP1185266A1 Amorphous form of fexofenadine hydrochloride |
| 03/13/2002 | EP1185265A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185263A2 Receptor agonists and antagonists |
| 03/13/2002 | EP1185262A1 PHARMACEUTICAL COMPOSITIONS CONTAINING 8-CHLORO-3($g(b)-DIETHYLAMINOETHYL)-4-METHYL-7-ETHOXYCARBONYL-METHOXY COUMARIN BASE AND THE SALTS THEREOF, WITH CHOLESTEROL-LOWERING ACTIVITY |
| 03/13/2002 | EP1185261A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185260A1 Ascorbic acid composition and method for treatment of aging or damaged skin |
| 03/13/2002 | EP1185259A1 Glycine cleavage system inhibitors as potential antipsychotics |
| 03/13/2002 | EP1185258A1 Therapeutic uses for nitric oxide inhibitors |
| 03/13/2002 | EP1185257A2 Treatment of acne using lipoic acid |
| 03/13/2002 | EP1185256A1 Utilization of a highly fluorinated oligomeric alkan in ophthalmology |
| 03/13/2002 | EP1185255A2 Neuroprotective and retinoprotective ophthalmologic medicines |
| 03/13/2002 | EP1185254A2 Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 03/13/2002 | EP1185253A2 Oral administration form for administering a fixed tramadol and diclofenac combination |
| 03/13/2002 | EP1185252A1 Novel formulations comprising lipid-regulating agents |
| 03/13/2002 | EP1185249A2 Methods and compositions for treating solid tumors |
| 03/13/2002 | EP1185246A1 Pharmaceutical composition for intranasal use of active substances that are insoluble and/or hardly soluble in water |
| 03/13/2002 | EP1185241A2 Compositions containing avenanthramides from oat extract |
| 03/13/2002 | EP1185240A1 Anhydrous antiperspirant cream compositions having improved perfume longevity |
| 03/13/2002 | EP1185237A1 Synergistic antibacterial combination |
| 03/13/2002 | EP1185232A1 Method of treating hair loss using sulfonyl thyromimetic compounds |
| 03/13/2002 | EP1185231A1 Method of treating hair loss using diphenylmethane derivatives |
| 03/13/2002 | EP1185230A1 Method of treating hair loss using diphenylether derivatives |
| 03/13/2002 | EP1185229A1 Method of treating hair loss |
| 03/13/2002 | EP1185171A1 Compositions and methods comprising morphine gluconate |
| 03/13/2002 | EP1132090A4 Method for producing an agent for treating non-cancerous pathologies of the organism |
| 03/13/2002 | EP1071431A4 Novel delivery of hydroxy carboxylic acids |
| 03/13/2002 | EP1041988A4 A method of preventing abuse of opioid dosage forms |
| 03/13/2002 | EP0983249B1 Processes and intermediates for preparing substituted indazole derivatives |
| 03/13/2002 | EP0977749B1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 03/13/2002 | EP0975219B1 Fungicide active substance combinations |
| 03/13/2002 | EP0948483B1 Farnesyl transferase inhibitors |
| 03/13/2002 | EP0946157B1 The topical use of kappa opioid agonists to treat ocular pain |
| 03/13/2002 | EP0944384B1 Transdermal drug delivery system for the treatment of heart diseases |
| 03/13/2002 | EP0939639A4 Methods and compositions for reducing or eliminating post-surgical adhesion formation |
| 03/13/2002 | EP0936908B1 Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (als) |
| 03/13/2002 | EP0901473B1 Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the novel compounds |
| 03/13/2002 | EP0876343B1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases |
| 03/13/2002 | EP0874634B1 Control of healing process |
| 03/13/2002 | EP0871616B1 Process for the preparation of anti-malarial drugs |
| 03/13/2002 | EP0869957B1 3(2h)-pyridazinone derivatives and pharmaceutical compositions containing these compounds |
| 03/13/2002 | EP0869805B1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 03/13/2002 | EP0859623B1 Absorbable prophylactic composition for protection against ionising or non-ionising electromagnetic waves |
| 03/13/2002 | EP0845989B1 Pain-alleviating drug composition |
| 03/13/2002 | EP0841909B1 Use of alicyclic diamines as immunomodulators |
| 03/13/2002 | EP0833573B1 Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals |